Publications by authors named "Gil-Ran Kim"

Claim this Profile
I
Immunoregulatory protein-hybrid extracellular vesicles via self-loadable backbone cyclization for oral inflammatory bowel disease therapy.
Yeonju Lee, Chaerim Yoo, Kyung-Min Kim, Sumin Kim, Yu Kyung Oh, Gil-Ran Kim, Young-Pil Kim

Bioact Mater· April 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Belatacept and regulatory T cells in transplantation: synergistic strategies for immune tolerance and graft survival.
Gil-Ran Kim, Kyung-Ho Nam, Je-Min Choi

Clin Transplant Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alleviating psoriatic skin inflammation through augmentation of Treg cells via CTLA-4 signaling peptide.
Woo-Sung Lee, Kyung-Ho Nam, Jong Hoon Kim, Won-Ju Kim, Jeong Eun Kim, Gil-Ran Kim

Front Immunol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steady-state memory-phenotype conventional CD4 T cells exacerbate autoimmune neuroinflammation in a bystander manner via the Bhlhe40/GM-CSF axis.
Min-Ji Cho, Hong-Gyun Lee, Jae-Won Yoon, Gil-Ran Kim, Ja-Hyun Koo

Exp Mol Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deletion of PD-1 destabilizes the lineage identity and metabolic fitness of tumor-infiltrating regulatory T cells.
Myeong Joon Kim, Kyungsoo Kim, Hyo Jin Park, Gil-Ran Kim, Kyeong Hee Hong, Dahae Kim

Nat Immunol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Understanding of Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) Signaling in T-Cell Biology and Disease Therapy.
Gil-Ran Kim, Je-Min Choi

Mol Cells· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unleashing cell-penetrating peptide applications for immunotherapy.
Ja-Hyun Koo, Gil-Ran Kim, Kyung-Ho Nam, Je-Min Choi

Trends Mol Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vivo Induction of Regulatory T Cells Via CTLA-4 Signaling Peptide to Control Autoimmune Encephalomyelitis and Prevent Disease Relapse.
Gil-Ran Kim, Won-Ju Kim, Sangho Lim, Hong-Gyun Lee, Ja-Hyun Koo, Sung-Min Kim

Adv Sci (Weinh)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cysteine-Containing Cell-Penetrating Peptide AP Enables Efficient Macromolecule Delivery to T Cells and Controls Autoimmune Encephalomyelitis.
Won-Ju Kim, Gil-Ran Kim, Hyun-Jung Cho, Je-Min Choi

Pharmaceutics· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis